CRISPR Therapeutics AG (CRSP) Current Taxes (2015 - 2026)

CRISPR Therapeutics AG has disclosed Current Taxes across 12 years of filings, most recently posting $638000.0 for Q1 2026.

• Current Taxes for Q1 2026 came in at $638000.0, down 48.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $638000.0 (down 48.59% YoY), and the FY2025 annual result was $1.1 million, up 146.78% from the prior year.
• Current Taxes came in at $638000.0 for Q1 2026 at CRISPR Therapeutics AG, down from $1.1 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $4.3 million in Q3 2022 to a low of $135000.0 in Q4 2022.
• The 5-year median for Current Taxes is $715000.0 (2025), against an average of $1.3 million.
• Across the five-year window, Current Taxes tumbled 95.88% in 2023 and jumped 376.14% in 2024, its largest moves.
• CRISPR Therapeutics AG's Current Taxes stood at $135000.0 in 2022, then jumped by 224.44% to $438000.0 in 2023, then grew by 2.97% to $451000.0 in 2024, then surged by 146.78% to $1.1 million in 2025, then tumbled by 42.68% to $638000.0 in 2026.
• The last three Current Taxes figures came in at $638000.0 (Q1 2026), $1.1 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.